Edgewise Therapeutics
EWTX
192 hedge funds and large institutions have $2.32B invested in Edgewise Therapeutics in 2025 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 63 reducing their positions, and 38 closing their positions.
88% more call options, than puts
Call options by funds: $61.6M | Put options by funds: $32.7M
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
6.09% more ownership
Funds ownership: 104.55% → 110.64% (+6.1%)
8% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 63
4% less funds holding
Funds holding: 200 → 192 (-8)
12% less capital invested
Capital invested by funds: $2.64B → $2.32B (-$321M)
16% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$101M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$28.1M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$25.2M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.2M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$18.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$33.9M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$19.3M |
| 3 |
D.E. Shaw & Co
New York
|
-$14.3M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9.76M |
EWTX Hedge Fund Activity: Q1 2025 in Review
192 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Edgewise Therapeutics (EWTX) for Q1 2025, worth a combined $2.32B — down 12% from $2.64B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of EWTX and 32 opened new positions — a net loss of 6 holders — while 63 trimmed existing stakes and 68 added.
The largest buyer was Perceptive Advisors, adding an estimated $101M. The largest seller was Frazier Life Sciences Management, exiting entirely with an estimated $33.9M sold.
- 192 institutional investors held Edgewise Therapeutics (EWTX) as of Q1 2025, down from 200 in Q4 2024.
- Funds reported $2.32B of Edgewise Therapeutics stock for Q1 2025, down 12% quarter-over-quarter.
- 32 funds opened new Edgewise Therapeutics positions in Q1 2025 and 38 closed out, a net change of -6 holders.
- The largest Edgewise Therapeutics buyer in Q1 2025 was Perceptive Advisors, an estimated $101M added.
- The largest Edgewise Therapeutics seller in Q1 2025 was Frazier Life Sciences Management, an estimated $33.9M sold.
Based on aggregated 13F filings for Q1 2025.